SignalCorporate
Actinium Pharmaceuticals names former CorMedix executive as CFO
Actinium Pharmaceuticals appoints former CorMedix executive as CFO, signaling leadership change.
Context
What happened: Actinium Pharmaceuticals (ATNM) appointed Matt David, M.D., as chief financial officer, overseeing finance, accounting, capital markets and investor relations.
Key numbers: More than two decades of experience.
Why it matters: David joins from CorMedix (CRMD), where he was executive vice president and chief business officer, bringing biopharmaceutical operating leadership, healthcare investment banking and equity research experience.
What changed
Actinium Pharmaceuticals (ATNM) appointed Matt David, M.D., as chief financial officer, overseeing finance, accounting, capital markets and investor relations.
Why it matters
David joins from CorMedix (CRMD), where he was executive vice president and chief business officer, bringing biopharmaceutical operating leadership, healthcare investment banking and equity research experience.